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        The canonical Wnt/    -catenin signaling is an 
evolutionary highly conserved cascade with mul-
tiple functions in proliferation, diff  erentiation, 
and apoptosis, among others (  1  ). In the hemato-
poietic system, Wnt signaling has been tightly 
linked to maintenance, activation, and prolifera-
tion of hematopoietic stem cells (HSCs) (  2  –  5  ), 
and aberrant expression of key players of this 
pathway is implicated in various leukemias (  6  ). 
    LEF-1   belongs to the family of LEF-1/T cell 
factor transcription factors that share homology 
with high mobility group proteins.   LEF-1   acts as 
a central transcription mediator of Wnt signaling, 
regulating cell cycle  –   and growth-relevant genes 
like   Cyclin D1   and   c-myc   (  6  –  8  ). Studies on Lef-1 
in hematopoietic development have been mainly 
restricted to the lymphoid lineages, where Lef-1 
has functions in T cell development and aff  ects 
proliferation and apoptosis in pro  –  B cells (  9, 10  ). 
Recent reports, however, also discuss specifi  c 
functions of Lef-1 independent of Wnt signaling 
(  11, 12  ), suggesting a more complex role of Lef-1 
in the development of hematopoietic tissues. 
  In this report, we demonstrate that   Lef-1   is 
expressed in murine HSCs as well as in diff  erent 
human leukemias. Aberrant expression of   Lef-1   
in murine BM perturbed normal hematopoietic 
development and induced B lymphoblastic leu-
kemias and Ig DH-JH –  rearranged acute myeloid 
leukemias (AML), which were propagated by a 
leukemic stem cell with lymphoid characteristics. 
Collectively, our data suggest a previously un-
known role of LEF-1 in early hematopoiesis and 
in the biology of acute leukemias. 
    RESULTS AND DISCUSSION   
  Expression of   Lef-1   in murine hematopoiesis 
  In a fi  rst step, we determined   Lef-1   mRNA ex-
pression levels in early murine hematopoietic 
development by real-time TaqMan PCR.   Lef-1   
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DJ  H   rearrangements of the IgH chain in a majority of pa-
tients. Moreover, it was shown that this leukemia was initi-
ated by a leukemic stem cell with lymphoid characteristics in 
a murine transplantation model (  13  ). When we examined 
  LEF-1   expression in a larger cohort of AML patients with 
normal karyotype (  n   = 194), there was a small subgroup (  n   = 24) 
of AML patients with increased   LEF-1   expression (range 443 
to 1,277 relative units) (  Fig. 1 C  ). Collectively, these results 
demonstrated that LEF-1 is widely expressed in human lym-
phoid leukemias, but also in human AML. 
  Constitutive expression of   Lef-1   perturbs normal 
hematopoietic development 
  We next sought to determine the functional relevance of 
Lef-1 in early hematopoiesis. For this, murine BM cells enriched 
for primitive progenitors were retrovirally engineered to ex-
press wild-type Lef-1 (Lef-1 WT) or a constitutive active 
mutant of Lef-1 (Lef-1 CA) using a murine stem cell virus  –
  based retroviral construct (  Fig. 2, A and B  ) and transplanted 
into lethally irradiated recipient mice.   Mice engrafted with 
Lef-1 WT  –   or Lef-1 CA  –  expressing BM cells showed a pro-
found disturbance of normal hematopoietic development 
(  n   = 12). Analysis of peripheral blood (PB) in nondiseased 
animals showed a twofold reduction of the proportion of 
B220  +   lymphoid cells in the transduced compartment com-
pared with empty vector control mice. Furthermore, both 
CD4  +   T cells and CD8  +   T cells were greatly reduced in the 
enhanced GFP (EGFP)  +   compartment in Lef-1  –  transplanted 
mice. Simultaneously, PB analysis showed a substantial increase 
in the proportion of Gr1  +   and Mac1  +   myeloid cells. In contrast, 
the nontransduced compartment of the PB of mice trans-
planted with Lef-1 WT or Lef-1 CA did not show any ab-
normalities compared with the control (not depicted). This 
accumulation of mature myeloid cells in the EGFP  +   com-
partment of the PB of transplanted animals was confi  rmed by 
morphological analyses. These changes led to an inversion of 
the lymphoid/myeloid ratio in these animals (  Fig. 2, C  –  H  ). 
  In a comparative analysis, Lef-1 CA seemed to induce a 
more pronounced perturbation of hematopoietic development 
than the Lef-1 WT gene. Furthermore, the skewing of the 
lymphoid/myeloid ratio toward the myeloid lineage was more 
pronounced in the Lef-1 CA group compared with Lef-1 WT 
(  Fig. 2, C  –  H  ). 
  Collectively, these data demonstrated that constitutive 
expression of Lef-1 results in a severe perturbation of hema-
topoiesis in transplanted animals with an increase in the pro-
portion of myeloid cells and a simultaneous proportional 
decrease of lymphoid cells in the PB. We observed that the 
alteration of the myeloid/lymphoid ratio was not accompanied 
by a signifi  cant change of the absolute cell numbers of circu-
lating WBCs (not depicted), suggesting that the drop in the 
lymphoid ratio could possibly result from the skewing of lineage 
fate decisions toward the myeloid lineage in early progenitors 
ectopically expressing the Lef-1 transcript. Furthermore, our 
observation that enforced expression of Lef-1 did not impair 
maintenance of normal murine B220  +  /Lin        B cells in vitro 
transcripts were detected at diff  erent stages of myeloid and 
lymphoid development. Of note, murine HSCs expressing 
cKit and Sca1, but lacking lineage markers (  Fig. 1 A  , LSK), 
were also positive for   Lef-1   transcription and showed a 
2.6-fold higher expression of Lef-1 as compared with more 
diff  erentiated Sca       /cKit  +  /Lin        progenitor cells.   Lef-1   expression 
was higher in more mature Gr1/Mac1  +   myeloid cells and 
showed highest expression levels in lymphoid cells (  Fig. 1 A  ). 
These data show for the fi  rst time expression of   Lef-1   in mu-
rine HSCs and are consistent with data in the human system 
documenting expression of   LEF1   in early human myeloid 
cells (  12  ). 
  Expression of   LEF-1   in human leukemias 
  We extended our analyses to human tissue and analyzed 
  LEF-1   expression in normal BM and in human leukemias by 
microarray analysis in   >  300 patients with acute leukemia. 
Leukemic samples as well as normal BM samples were positive 
for   LEF-1   expression. However, there was an     13-fold higher 
relative expression of   LEF-1   in acute lymphoblastic leukemia 
(ALL) samples (  n   = 47) compared with AML (  n   = 73), possibly 
refl  ecting the higher expression of the transcription factor in 
lymphoid tissue. The levels of LEF-1 expression, however, 
did not correlate with particular subtypes of AML or ALL (not 
depicted). Although most of the AML cases were characterized 
by low   LEF-1   expression, intriguingly, two of the AML cases 
showing highest   LEF-1   levels were diagnosed as CALM/
AF10  +   AML (  Fig. 1 B  ), which was recently shown to harbor 
    Figure 1.         Lef-1 expression in murine hematopoietic tissue and 
human leukemia.   (A) Lef-1 mRNA expression in FACS-sorted murine 
hematopoietic BM subpopulations. Data represent means plus SD of 
triplicates (  n   = 3). K  + S     L     ,  cKit + Sca     Lin     ;  GM ++ ,  Gr1 + Mac1 + ;  B + 43 + 24 + , 
B220  + CD43 + CD24 + ;  B + 19 + ,  B220 + CD19 + ;  B + 43     IgM     ,  B220 + CD43     IgM     . 
(B and C) Expression levels of LEF-1 were determined in two microarray 
datasets: 120 samples from 13 different leukemia subtypes (B) and a se-
ries of 194 expression profi  les from AML samples with normal karyotype (C). 
(B) Comparison of relative LEF-1 mRNA expression in AML and ALL pa-
tients. Bars indicate the median. Red dots indicate CALM/AF10  +   AML/ALL 
cases. (C) Relative expression of LEF-1 in 194 AML patient samples with 
normal karyotype (NK).     JEM VOL. 205, March 17, 2008  517 
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Therefore, constitutive expression of   Lef-1   in early hema-
topoietic progenitor cells might result in a shift toward the 
myeloid lineage. This important role of Lef-1 in myeloid 
development is supported by our data showing expression in 
early and myeloid hematopoietic cells in mice. 
compared with nontransduced controls argued against a di-
rect anti-proliferative eff  ect of Lef-1 (not depicted). Of note, 
a pivotal role of LEF-1 in myeloid diff  erentiation was re-
cently described in the human system (  12  ). The same report also 
demonstrated that C/EBP     is a direct target gene of LEF-1. 
    Figure 2.         Lef-1 severely perturbs normal hematopoietic differentiation.   (A) Retroviral constructs for expression of WT and mutant constitutive 
active (CA)   Lef-1   proteins. As control, the empty EGFP vector was used. BCBD,     -catenin binding domain; CAD, context-dependent activation domain; 
HMG, high mobility group DNA binding domain; NLS, nuclear localization signal; LBDBC, Lef-1 binding domain of     -catenin; L, linker; LTR, long-terminal 
repeat; IRES, internal ribosomal entry site; EGFP, enhanced GFP. (B) Expression of Lef-1. Western blot analysis of cellular extracts from NIH 3T3 cells trans-
fected with the different constructs (left image, the molecular mass is indicated); TaqMan real-time RQ-PCR with cDNA (triplicates) of BM cells from 
Lef-1 WT (  n   = 2) and Lef-1 CA leukemic mice (  n   = 2) compared with the endogenous Lef-1 mRNA expression level in a healthy EGFP control animal (middle); 
and quantifi  cation of Lef-1 expression level by RQ-PCR in BM cells freshly infected with Lef-1 WT, Lef-1 CA, and empty vector control using highly 
purifi  ed EGFP  +   populations (right). (C  –  E) Flow cytometry analysis of PB samples of (C) a Lef-1 WT (no. 8) and (D) a Lef-1 CA (no. 10)   –  engrafted mouse, 
respectively, compared with a control EGFP animal (E). Representative dot plots with the proportion of positive stained cells within the EGFP  +   compartment 
compared with the EGFP        compartment are shown. (F) Accumulation of mature myeloid cells in Lef1-transplanted animals. Wright-Giemsa  –  stained cyto-
spins from PB of a Lef-1 CA  –  transduced mouse (no. 10; left image, GFP  +   compartment; middle image, GFP        compartment) and a control animal (right 
image). Bar, 10   μ  m. (G) Percentage of lymphoid and myeloid cells in PB in transduced animals. Mean values   ±   SEM are indicated (  n   [WT] = 20,   n   [CA] = 12, 
  n   [EGFP] = 8; *, P   <   0.02; **, P   <   0.001). Signifi  cant differences between Lef-1 WT and Lef-1 CA animals are indicated when present. (H) Lymphoid/myeloid 
ratio in PB of transduced mice. Lymphoid cells included B220  + ,  CD4 +  , and CD8  +   cells, and myeloid cells included Mac1  + /Gr1 + ,  Mac1 + /Gr1      , and Mac1      /Gr1 +  
cells. Individual mice are indicated by different colors and were analyzed at one or multiple time points after transplantation. The median is presented as 
a black bar (*, P   <   0.02; **, P   <   0.002).     518 LEF-1 INDUCES ACUTE LEUKEMIA IN MICE | Petropoulos et al.
inhibition of LEF-1 but not of     -catenin aff  ected prolifera-
tion and apoptosis of this cell population, supporting a model 
of a     -catenin  –  independent function of LEF-1 in early human 
myelopoiesis (  12  ). 
  Constitutive Lef-1 induces acute leukemia 
in transplanted mice 
  After a median latency of 12 mo, 10 of 12 animals transplanted 
with BM-expressing Lef-1 WT or Lef-1 CA developed a lethal 
  Previous reports have documented that deregulated ex-
pression of   LEF-1   can infl  uence both lymphoid and myeloid 
development. Earlier reports have demonstrated that Lef-1 de-
fi  ciency is associated with defects in pro  –  B cell proliferation 
and survival, but not B cell diff  erentiation (  10  ). The fact that 
in our model rather similar eff  ects were observed in mice trans-
planted with WT or constitutive active Lef-1 might sug-
gest that Lef-1 can function independently of Wnt signaling 
in hematopoietic tissue. In human CD34  +   progenitor cells, 
    Figure 3.         Lef-1 overexpression induces acute leukemia.   (A) Survival curve of mice transplanted with BM cells expressing Lef-1 WT, Lef-1 CA, and 
EGFP as well as survival of secondary recipient mice transplanted with BM from diseased primary mice. (B) Blood smears (BS) and cytospin preparations 
from PB and BM of a representative animal with AML (no. 8, 1  –  3) and ALL (no. 13, 4  –  6). Slides were stained with Wright-Giemsa. Bars: 1, 60   μ  m; 4, 40   μ  m; 
2 and 5, 30   μ  m; 3 and 6, 20   μ  m. (C) Immunophenotype analysis of diseased mice. Representative dot plots from the BM and SP of a mouse with 
myeloproliferative disease (MPD, 1  –  4, no. 7), with AML (5  –  8, no. 11) and ALL (9  –  12, no. 14). The Mac1/Gr1 and CD43/B220 costainings were gated on GFP  +  
cells. The percentage of positive-stained cells is indicated. (D) Histochemical and immunohistological analysis of diseased mice. Panels 1  –  3, B-ALL (mouse 
no. 4); panels 1 and 2, tumor cells infi  ltrating lymph nodes staining positive for TdT and negative for CD3; residual normal T cells in the lymph node are 
CD3  +   (2, right side), whereas infi  ltrated leukemic blast cells are TdT  +  , but CD3        (1; left side and insets 1 and 2, SP). Panels 4  –  8: primary AML (4 and 5, 
mouse no. 9; 6  –  8, mouse no. 10). Panels 9 and 10: diseased secondary recipient of mouse number 10. H  &  E, hematoxylin and eosin; MPO, myeloperoxi-
dase; CAE,   N  -acetyl-chloroacetate esterase; TdT, terminal deoxynucleotidyl transferase; LN, lymph node; LV, liver. Bars: 8, 200   μ  m; 1, 2, and 10, 100   μ  m; 
3, 6, and 7, 50   μ  m; 4, 5, 9, and insets 1 and 2, 25   μ  m.     JEM VOL. 205, March 17, 2008  519 
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populations isolated from mice with ALL or AML revealed an 
immature, blast-like appearance of the B220  +  Mac1        cells, 
whereas the B220       Mac1  +   cells displayed a more diff  erenti-
ated phenotype with granulocytic characteristics (  Fig. 4 A  ).   
The immature nature of the B220  +   population was further 
confi  rmed by FACS analysis showing expression of CD43 
and AA.4.1, but negativity for CD19 (Fig. S4, available at 
hematological disease. Median survival of mice in the Lef-1 
WT group was 310 d (  n   = 3, range 141  –  589 d), whereas 7 of 
7 Lef-1 CA  –  transduced mice died after an average of 377 d 
after transplant (  n   = 7, range 91  –  527 d) (  Fig. 3 A  ).   5 out of 
10 evaluable diseased animals showed highly elevated levels 
of WBCs (P   <   0.02), whereas 7 of the mice were characterized 
by mild to severe anemia (P  <   0.001). 8 out of 11 evaluable mice 
suff  ered from splenomegaly (P   <   0.02) (Table S1, available 
at http://www.jem.org/cgi/content/full/jem.20071875/
DC1). All evaluable diseased mice showed increased numbers 
of blast cells in the PB, BM (  Fig. 3 B  ), or spleen (SP). Histo-
logical sections demonstrated infi  ltration of blasts in multiple 
nonhematopoietic organs (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20071875/DC1). According 
to the Bethesda proposal for classifi  cation of nonlymyphoid 
hematopoietic neoplasms in mice, seven animals suff  ered from 
acute leukemia, which was retransplantable, and had   >  20% 
blasts in PB, BM, or SP (  Fig. 3, A and B  , and Table S1) (  14  ). 
In two mice, a myeloproliferative disease was diagnosed with 
a blast percentage of   ≤  20%, accumulation of mature neutro-
phils in the PB and BM, or lack of transplantability into sec-
ondary recipients (Table S1). 
  More detailed analysis demonstrated that four mice died 
of an AML with maturation (  14  ). The diagnosis of AML was 
supported by fl  ow cytometry demonstrating a high proportion 
of Gr1  +   and Mac1  +   cells in the PB, BM, and SP (  Fig. 3 C  ). 
In the immunohistochemistry, the blasts were positive for 
myeloperoxidase and chloracetate esterase and negative for 
CD3 (  Fig. 3 D  ). Three mice succumbed to acute B lympho-
blastic leukemia displaying lymphoid-like blast cells (  Fig. 3 B  ), 
a high percentage of B220  +  /CD43  +   cells in the PB, BM, and 
SP (  Fig. 3 C  ) as well as positivity of the blast cells for terminal 
deoxynucleotidyl transferase (TdT) and B220 in histological 
sections (  Fig. 3 D  ). In mice suff  ering from myeloproliferation, 
a high proportion of BM and splenic cells stained positive for 
Gr1 and Mac1 (  Fig. 3 C  ). Clonal analysis by Southern blotting 
of leukemic mice revealed a monoclonal disease in all exam-
ined primary and secondary animals (Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20071875/DC1). A com-
parative analysis between mice with Lef-1 WT versus Lef-1 
CA positive leukemia showed a trend toward more pro-
nounced disease manifestations in the Lef-1 CA experimental 
group, although the diff  erences were not signifi  cant (Table S1). 
  Lef-1  –  induced AMLs are propagated by a leukemic stem 
cell with lymphoid characteristics 
  When the ALLs and AMLs were examined in more detail, 
ALL and AML cases shared key biological characteristics: all 
leukemias independent of their phenotype were characterized 
by a distinct B220  +  Mac1  +   cell population in the PB, BM, and 
SP. In addition, all the diseased mice and, of note, also mice 
suff  ering from AML revealed a B220  +  Mac1        population. In the 
AML cases, this B220  +  Mac1        population comprised 6.3 and 
1.6% in BM and PB cells, respectively (Table S2, available at 
http://www.jem.org/cgi/content/full/jem.20071875/DC1). 
Morphological analysis of the diff  erent highly purifi  ed BM 
    Figure 4.         Lef-1  –  induced acute leukemias are propagated by a LSC 
with lymphoid characteristics.   (A) Morphology of sorted BM populations 
of a representative AML (1  –  3, no. 10) and an ALL case (3  –  6, no. 14). B  + M     , 
B220  + /Mac1     ;  BM ++ ,  B220 + Mac1 + ;  B     M + ,  B220     Mac1 +  . Bars, 20   μ  m. 
(B) Multiplex PCR for DJ  H   loci rearrangement in diseased mice. Line 2, 
germline control (GL, myeloid cell line 32D); line 3, splenic B220 cells. 
(C) Seeding effi  ciency of B  + MG     ,  BMG +++  , and B      MG +   populations  from 
BM cell cultures of leukemic mice (  n   = 3; mouse nos. 4, 10, and 11; Table S1). 
Shown are the mean values   ±   SEM. (D) B  + M       cells from a cell population 
generated from a single B  + M       cell (mouse no. 4) developed into BM  2+   and 
B      M +   populations. (E) Multiplex PCR for DJ  H   rearrangement for highly 
purifi  ed B  + M     ,  BM 2+  , and B      M +   cells generated from a single B  + M       cell 
in vitro. CL, cell line.     520 LEF-1 INDUCES ACUTE LEUKEMIA IN MICE | Petropoulos et al.
turbations in the Wnt/    -catenin pathway can induce a desta-
bilization of lineage fate decisions in early committed progenitors, 
which might be an important prerequisite for the develop-
ment of the B220  +  CD43  +  AA4.1  +   LSC in our model. 
  Interestingly, the expression profi  le of crucial transcription 
factors and growth factor receptors revealed a striking similarity 
between the leukemic myeloid and lymphoid bulk popula-
tion. Both AML and ALL cases showed a promiscuous ex-
pression of lymphoid and myeloid regulatory factors with 
positivity for both the myeloid factors   C/ebp       and   C-fms   and 
the lymphoid transcription factors   E2A   and   Ebf-1  , whereas 
both types of acute leukemias were low/negative for   Pax5  , 
which is in line with our observation that ALL and AML 
cases displayed DJ  H   but not VDJ  H   rearrangements (  Fig. 5, 
B and C  ) (  17  –  20  ). 
  Our observations indicate that deregulated expression of 
  Lef-1   induces acute B lymphoblastic leukemias, but also DJ  H  -
rearranged AMLs, which are propagated by a LSC with char-
acteristics similar to early lymphoid progenitors. We just recently 
reported that murine CALM/AF10  +   AML is initiated by a 
B220  +   myeloid marker        leukemic stem cell and that both 
murine and human CALM/AF10  +   AML cases are DJ  H  rear-
ranged (  13  ). Thus, our observations show that not only an ap-
propriate leukemia-specifi  c fusion gene, but also a transcription 
http://www.jem.org/cgi/content/full/jem.20071875/DC1). 
We then tested AML and ALL samples for IgH DJ  H   rearrange-
ments. Strikingly, clonal DJ  H   but not VDJ  H   rearrangements 
were detected in all three subpopulations in acute leuke-
mias independent of the phenotype (  Fig. 4 B  , Table S2, and 
not depicted). 
  To further explore the characteristics of the B220  +   myeloid 
marker        cell population in these leukemias, B220  +  Mac1       Gr1        
(B  +  MG       ), B220       Mac1  +  Gr1  +   (B       MG  +  ), and B220  +  Mac1  + 
Gr1  +   (BMG  +++  ) cells were highly purifi  ed from BM cell 
cultures of three leukemic mice (AML,   n   = 2; ALL,   n   = 1). 
Of note, the B  +  MG        cell population displayed the highest 
proliferative potential in vitro (Fig. S3, available at http://
www.jem.org/cgi/content/full/jem.20071875/DC1). In addi-
tion, the B  +  MG        cells had the highest proliferative poten-
tial at the single cell level compared with the BMG  +++   and 
B       MG  +   populations (  Fig. 4 C  ). These data demonstrated that 
ALL and AML cases induced by Lef-1 shared striking similar-
ities in the hierarchical organization of the malignant clone. 
B  +  MG        cells were then isolated from a cell population derived 
from a single B  +  MG        cell of a mouse suff  ering from ALL and 
propagated in vitro. Importantly, these myeloid marker        DJ  H  -
rearranged cells were able to generate the BMG  +++   and the 
B       MG  +   cell populations harboring the identical clonal DJ  H   
rearrangement (  Fig. 4, D and E  ). These data indicated that in 
this model, B  +  MG        cells have the highest proliferative potential 
at the single cell level and can give rise to DJ-rearranged myeloid 
cells lacking B220 expression. 
  As these observations suggested that the leukemia-propa-
gating cell in Lef-1  –  induced AML resides in the B  +  MG        
population, we performed a limiting dilution transplantation 
assay using leukemic BM from a representative AML mouse 
(Table S1, no. 10) to calculate the frequency of leukemic stem 
cells (LSCs) in the diff  erent subpopulations. In these experi-
ments, the B  +  MG        cell population was highly enriched for 
LSCs with a 20- and 60-fold increase of the LSC frequency 
compared with the BMG  +++  /B       MG  +   and the B       MG        cell 
compartments, respectively (  Fig. 5 A  ).   In summary, these ob-
servations indicate that deregulated expression of Lef-1 induces 
acute B lymphoblastic leukemias as well as DJ  H  -rearranged 
AMLs, which are propagated by an LSC with lymphoid char-
acteristics. These observations that constitutive expression of 
Lef-1 induces the development of a leukemic B  +  M        cell pop-
ulation, which exhibits DH-JH rearrangements and is nega-
tive for Pax5, are consistent with reports on the impact of 
constitutive     -catenin expression in hematopoietic progeni-
tors (  15, 16  ): retroviral expression of     -catenin into murine 
HSCs induced the outgrowth of c-Kit  low  Sca-1  low   CD19        cells, 
which interestingly were highly positive for B220, whereas en-
forced expression of     -catenin in normal murine myeloid or 
lymphoid cells led to uncommitted cells with multilineage 
diff  erentiation potential. In the latter experiments, enforced 
expression of     -catenin in lymphoid progenitors rapidly in-
creased C/ebp    , reduced Ebf/Pax5 expression, and induced 
outgrowth of c-kit  +  Sca-1  low/     B220  +  CD43  +  AA4.1  +   cells with 
DH-JH rearrangements. These data demonstrated that per-
    Figure 5.         Frequency of leukemia-propagating cells and transcrip-
tional profi  le analysis.   (A) Highly purifi  ed B  + MG     ,  BMG +++ ,  B     MG + ,  and 
triple negative B      MG       cell populations from a primary mouse with AML 
(no. 10) were injected into cohorts of secondary mice. The frequency of 
leukemia-propagating cells in each of the populations is indicated. For 
details see Table S3, available at http://www.jem.org/cgi/content/full/
jem.20071875/DC1. (B) Analysis of mRNA expression of regulatory factors 
in BM cells of diseased mice by semiquantitative RT-PCR. BM bulk (BM ctrl), 
Mac1  +   BM cells (BM Mac1  +  ), and B220  +   splenic cells (SP B220  +  ) of a non-
transplanted mouse served as controls. (C) Analysis of C/ebp     expression 
in subpopulations generated from a B220  + Mac1       single cell originating 
from an ALL-diseased mouse single cell. HPRT, hypoxanthine guanine 
phoshoribosyltransferase.   JEM VOL. 205, March 17, 2008  521 
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  The frequency of leukemia-propagating cells was determined as described 
previously (  13  ). Highly purifi  ed B220  +  Gr1       Mac1       , B220  +  Gr1  +  Mac1  +  , 
B220       Gr1  +  Mac1  +  , and triple negative B220       Gr1       Mac1        cell populations 
from a primary mouse with AML (no. 10) were injected into cohorts of le-
thally irradiated secondary mice using fi  ve dilutions of sorted cell populations 
ranging from 10 to 5.0   ×   10  4   cells per donor mouse. 7.5   ×   10  5   carrier cells 
(nontransduced BM from a syngenic disease-free mouse) were added to each 
sample for radioprotection. Diseased mice were killed and assessed for leuke-
mia development. The frequency of leukemia-propagating cells was calcu-
lated using Poisson statistics using the L-Calc Limiting dilution analysis 
software (version 1.1; StemSoft Inc.). 
  Transcriptional profi  ling of both leukemic BM samples and sorted 
leukemic cell line subpopulations was performed by semiquantitative PCR 
using intron-spanning primers when available (sequences upon request). 
  Western blot.     Protein expression of Lef-1 constructs was demonstrated 
by Western blotting using standard procedures, applying anti  –  Lef-1 poly-
clonal goat antibody and secondary anti  –  goat peroxidase-conjugated anti-
body (Santa Cruz Biotechnology, Inc.). 
  Microarray.     Total mRNA was isolated from patient samples and processed 
and analyzed as described previously (  23  ). The .CEL fi  le data from the sam-
ples used in the comparison were normalized together according to the pro-
cedure described by Huber et al. (  24  ). Normalized expression data were then 
analyzed with the R software package and the   “  boxplot  ”   function (http://
www.r-project.org). Expression signal intensities are given on a logarithmic 
scale or as relative expression. For the comparison of LEF-1 transcript levels, 
the following diff  erent AML or ALL subtypes were analyzed: AML: M2, 
M3, M4eo, FLT3-length mutation, AML with MLL translocations, and 
normal karyotype and complex karyotype; ALL: pro  –  B ALL, Philadelphia 
chromosome  +   ALL, and ALL with MLL rearrangements. 
  Statistical analysis.     Data were evaluated by using the   t   test for dependent 
or independent samples. Diff  erences with p-values of   <  0.05 were considered 
statistically signifi  cant. 
  Online supplemental material.     Fig. S1 shows leukemic blast infi  ltration 
into nonhematopoietic tissue. Fig. S2 shows Lef-1  –  induced leukemias to be 
of monoclonal origin. Fig. S3 highlights highest proliferative potential of 
B  + MG        cells in vitro, and Fig. S4 displays additional immunophenotypic 
characterization of leukemic B220  +  cells. Table S1 shows the critical charac-
teristics of diseased mice, Table S2 displays percentages of B220  +  cells in 
Lef-1  –  induced leukemias, and Table S3 highlights incidence and latency of 
leukemias in the CRU. The online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20071875/DC1. 
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